Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Immunology

Internal Medicine

Gastroenterology

Genetics

Show all topics

DOI

10.1016/s0140-6736(15)60027-7

Other Formats

PDF